Wakao Hiroshi, Wakao Rika, Sakata Sakura, Iwabuchi Kazuya, Oda Atsushi, Fujita Hiroyoshi
Department of Environmental Biology, School of Medicine, Hokkaido University, N15W7, Sapporo 060-8638, Japan.
FASEB J. 2008 Jul;22(7):2223-31. doi: 10.1096/fj.07-104687. Epub 2008 Mar 6.
The ectopic expression of the Notch receptor ligand delta-like 1 on stromal cells allows the induction of T cells from embryonic stem cells (ESCs). However, these in vitro-generated T cells are not transplantable because they are too immature to mount an immune response in an immunocompromised animal. We efficiently generated a subset of T cells called invariant natural killer T (iNKT) cells from ESCs derived from peripheral iNKT cells using somatic cell nuclear transfer (ntESCs). These iNKT cells matured autonomously in vivo and exhibited an adjuvant effect accompanying the production of interferon-gamma in an antigen-specific manner. This adjuvant effect culminated in the inhibition of inoculated tumor cell growth. Our results indicate that ntESC-derived iNKT cells are transplantable lymphocytes that will be beneficial for the induction of immune tolerance and the treatment of autoimmune diseases, tumors, and infections.
Notch受体配体delta样1在基质细胞上的异位表达可诱导胚胎干细胞(ESC)产生T细胞。然而,这些体外生成的T细胞不可移植,因为它们过于不成熟,无法在免疫受损动物体内引发免疫反应。我们利用体细胞核移植(ntESC)从外周不变自然杀伤T(iNKT)细胞来源的ESC中高效产生了一类名为不变自然杀伤T(iNKT)细胞的T细胞亚群。这些iNKT细胞在体内自主成熟,并以抗原特异性方式伴随干扰素-γ的产生表现出佐剂效应。这种佐剂效应最终导致接种的肿瘤细胞生长受到抑制。我们的结果表明,ntESC来源的iNKT细胞是可移植的淋巴细胞,将有利于诱导免疫耐受以及治疗自身免疫性疾病、肿瘤和感染。